Gemcitabine and cisplatin combination chemotherapy as first-line treatment in patients with metastatic breast cancer.

被引：0
|
作者：
Alauddin, Z [1 ]
Shaharyar, A [1 ]
机构：
[1] Mayo Hosp, King Edward Med Coll, Lahore, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：56S / 56S
页数：1
相关论文
共 50 条
  • [1] Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer.
    Gokmen, E
    Sezgin, C
    Karabulut, B
    Vazquez, A
    Sanal, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 85S - 85S
  • [2] First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Panopoulos, C
    Chrissohoou, M
    Apostolikas, N
    Efremidis, AP
    BREAST, 2005, 14 (02): : 136 - 141
  • [3] Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma
    Lee, QW
    Kang, JH
    Kim, HG
    Lee, JS
    Lee, JS
    Jang, JS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 127 - 131
  • [4] Gemcitabine and S-1 as first-line chemotherapy in patients with metastatic or advanced pancreatic cancer.
    Fang, Weijia
    Zhao, Peng
    Zheng, Yi
    Jiang, Weiqin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] Review of gemcitabine plus taxane combination therapy in the first-line treatment of metastatic breast cancer
    Colomer, Ramon
    EJC SUPPLEMENTS, 2008, 6 (04): : 9 - 12
  • [6] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [7] Review of gemcitabine plus taxane combination therapy in the first-line treatment of metastatic breast cancer
    Colomer, Ramon
    EJC SUPPLEMENTS, 2008, 6 (08): : 9 - 12
  • [8] The cost-effectiveness of bevacizumab in combination with paclitaxel in first-line treatment of patients with metastatic breast cancer.
    Montero, A. J.
    Gluck, S.
    Lopes, G. D. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer
    Possinger, K
    Kaufmann, M
    Coleman, R
    Stuart, NSA
    Helsing, M
    Ohnmacht, U
    Arning, M
    ANTI-CANCER DRUGS, 1999, 10 (02) : 155 - 162
  • [10] First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
    Sung Yong Han
    Dong Uk Kim
    Young Mi Seol
    Suk Kim
    Nam Kyung Lee
    Seung Baek Hong
    Hyung-Il Seo
    World Journal of Clinical Cases, 2020, (18) : 4022 - 4033
12345